Cargando…

Natriuretic peptide level at heart failure diagnosis and risk of hospitalisation and death in England 2004–2018

OBJECTIVE: Heart failure (HF) is a malignant condition requiring urgent treatment. Guidelines recommend natriuretic peptide (NP) testing in primary care to prioritise referral for specialist diagnostic assessment. We aimed to assess association of baseline NP with hospitalisation and mortality in pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taylor, Clare J, Lay-Flurrie, Sarah L, Ordóñez-Mena, José M, Goyder, Clare R, Jones, Nicholas R, Roalfe, Andrea K, Hobbs, FD Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Heart Failure and Cardiomyopathies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921592/ https://www.ncbi.nlm.nih.gov/pubmed/34183432 http://dx.doi.org/10.1136/heartjnl-2021-319196

Ejemplares similares

Body mass index and survival in people with heart failure
por: Jones, Nicholas R, et al.
Publicado: (2023)

Essential components in natriuretic peptide-guided management of heart failure: an intervention synthesis
por: Oke, Jason, et al.
Publicado: (2018)

Improvements of predictive power of B-type natriuretic peptide on admission by mathematically estimating its discharge levels in hospitalised patients with acute heart failure
por: Anegawa, Eiji, et al.
Publicado: (2021)

Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms
por: Takashio, Seiji, et al.
Publicado: (2019)

Prospective development and validation of a model to predict heart failure hospitalisation
por: Cubbon, R M, et al.
Publicado: (2014)

Echocardiographic subtypes of heart failure in consecutive hospitalised patients with dyspnoea
por: Nielsen, Olav Wendelboe, et al.
Publicado: (2019)

Impact of missed treatment opportunities on outcomes in hospitalised patients with heart failure
por: Walker, Simon, et al.
Publicado: (2017)

Vascular comorbidities worsen prognosis of patients with heart failure hospitalised with COVID-19
por: Mok, Jacob, et al.
Publicado: (2021)

Value of natriuretic peptides and tissue Doppler imaging in the estimation of left ventricular filling pressure in patients with cardiac amyloidosis
por: Brun, Stéphanie, et al.
Publicado: (2019)

Diagnostic yield of a heart failure referral pathway using N-terminal pro-brain natriuretic peptide
por: Zegard, Abbasin, et al.
Publicado: (2023)

Five-year outcomes following left ventricular assist device implantation in England
por: Bottle, Alex, et al.
Publicado: (2021)

Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure
por: Cubbon, Richard M, et al.
Publicado: (2016)

Hospitalisation and life support in the year before and during heart transplantation: a French national study
por: Cantrelle, Christelle, et al.
Publicado: (2018)

Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004–2011
por: Lampropulos, Julianna F, et al.
Publicado: (2014)

Multispecialty multidisciplinary input into comorbidities along with treatment optimisation in heart failure reduces hospitalisation and clinic attendance
por: Essa, Hani, et al.
Publicado: (2022)

One-year rehospitalisation and mortality after acute heart failure hospitalisation: a competing risk analysis
por: Marques, Irene, et al.
Publicado: (2023)

Natriuretic peptide testing and heart failure diagnosis in primary care: diagnostic accuracy study
por: Taylor, Clare J, et al.
Publicado: (2022)

Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy
por: Law, Steven, et al.
Publicado: (2022)

Prognostic significance of repeated brain natriuretic peptide measurements after percutaneous transluminal septal myocardial ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy
por: Akita, Keitaro, et al.
Publicado: (2018)

A COMBINED APPROACH USING HIGH-SENSITIVE TROPONIN I AND N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE FOR RISK STRATIFICATION IN PATIENTS WITH CORONAVIRUS DISEASE 2019
por: Sano, Madoka, et al.
Publicado: (2023)

Iron deficiency in 78 805 people admitted with heart failure across England: a retrospective cohort study
por: Beattie, James M, et al.
Publicado: (2020)

Research priorities in advanced heart failure: James Lind alliance priority setting partnership
por: Taylor, Clare J, et al.
Publicado: (2020)

Role of N-terminal pro-B type natriuretic peptide as a predictor of poor outcomes in patients with HFrEF receiving primary prevention implantable cardioverter-defibrillator therapy: a systematic review and dose–response meta-analysis
por: Prameswari, Hawani Sasmaya, et al.
Publicado: (2023)

Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy
por: Sugrue, Alan, et al.
Publicado: (2017)

A hundred heart failure deaths: lessons learnt from the Dr Foster heart failure hospital mortality alert
por: Tran, Patrick, et al.
Publicado: (2019)

Long term trends in natriuretic peptide testing for heart failure in UK primary care: a cohort study
por: Roalfe, Andrea K, et al.
Publicado: (2021)

In-hospital treatment and outcomes of heart failure in specialist and non-specialist services: a retrospective cohort study in the elderly
por: Parmar, Kishan R, et al.
Publicado: (2015)

Complications and prognosis of patients undergoing apical or septal right ventricular pacing
por: Spath, Nick B, et al.
Publicado: (2019)

Measures of endothelial dysfunction predict response to cardiac resynchronisation therapy
por: Warriner, David R, et al.
Publicado: (2016)

Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis
por: Stirrat, Colin G, et al.
Publicado: (2018)

Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity
por: de Feria, Alejandro E, et al.
Publicado: (2021)

Changes in heart failure management and long-term mortality over 10 years: observational study
por: Bottle, Alex, et al.
Publicado: (2022)

The role of cardiac biomarkers for predicting left ventricular dysfunction and cardiovascular mortality in acute exacerbations of COPD
por: Buchan, Alice, et al.
Publicado: (2015)

What can we learn from RELAX-AHF compared to previous AHF trials and what does the future hold?
por: Cannon, Jane A, et al.
Publicado: (2015)

Real-world presentation with heart failure in primary care: do patients selected to follow diagnostic and management guidelines have better outcomes?
por: Bottle, Alex, et al.
Publicado: (2018)

Higher number of live births is associated with left ventricular diastolic dysfunction and adverse cardiac remodelling among US Hispanic/Latina women: results from the Echocardiographic Study of Latinos
por: Aggarwal, Shivani R, et al.
Publicado: (2017)

Update in imaging of cancer therapy-related cardiac toxicity in adults
por: de Baat, Esmée C, et al.
Publicado: (2021)

Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates
por: Janoušek, J, et al.
Publicado: (2009)

Vitamin D levels and left ventricular diastolic function
por: Pandit, Anil, et al.
Publicado: (2014)

Characteristics of circulatory failure after out-of-hospital cardiac arrest: a prospective cohort study
por: Langeland, Halvor, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k8tsdeurepbkoo1ugr25qbsjq6